Group 1 - Aoyang Group is planning to transfer the controlling stake of its listed company Aoyang Health, which may lead to a change in actual control [1][4] - Aoyang Group was established in 1998 and has over 30 subsidiaries and more than 5,000 employees, focusing on health, green ecology, and textile industries [3][4] - The company has undergone significant transformations, including the sale of its viscose business to a leading industry player and a shift towards the health industry [4][5] Group 2 - Aoyang Health's stock was suspended from trading starting September 9, with an expected suspension period of no more than two trading days [1] - The identity of the potential buyer for Aoyang Health's controlling stake remains uncertain, with speculation about possible related parties [6] - Aoyang Group has previously reduced its stake in Aoyang Shunchang, now known as Weilan Lithium, through multiple transactions, leading to a decrease in its controlling position [5]

Group 1 - Tianpu Co., Ltd. experienced a significant stock price increase of 185.29% from August 22 to September 10, leading to a halt for further investigation due to abnormal trading [4] - Baiyin Nonferrous Metals has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure [5] - Qingshan Paper Industry confirmed that its production and operational activities are normal, with no significant changes in daily operations [6] Group 2 - Aoyang Health announced that its stock will continue to be suspended due to ongoing negotiations regarding a share transfer by its controlling shareholder [7] - ST Jinke will implement a capital reserve transfer to increase share capital, resulting in a one-day stock suspension [8] - ST Haofeng's stock will resume trading on September 11 after a share transfer agreement was signed, making Zhixin Network the controlling shareholder [9] Group 3 - Fushun Special Steel's stock will be suspended for one day due to a tender offer for shares by Ningbo Meishan Free Trade Port Zone Jincheng Shazhou Equity Investment Co., Ltd. [10] - Fuliwang's subsidiary plans to invest 500 million yuan in a high-end wire material research and production project [11] - ST Tianmao's application for voluntary delisting has been accepted by the Shenzhen Stock Exchange [12] Group 4 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of Qinhuai Data China [13] - Betta Pharmaceuticals intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [14] - Longzi Co., Ltd. plans to acquire a 67.5% stake in Chongqing Time for approximately 92.475 million yuan [15] Group 5 - Dongfang Guoxin plans to establish a joint venture for a technology company with Shunyi Jin Kong [16] - ST Lianshi signed a pre-restructuring investment agreement with selected investors [18] - Shaanxi Construction Group won four construction projects worth over 5 billion yuan in August [19] Group 6 - Dema Technology won a smart logistics project with a well-known Latin American e-commerce giant, valued at approximately 290 million yuan [20] - Mongolian Grass Ecology's subsidiary led a consortium to win a 225 million yuan ecological restoration project [21] - Dajin Heavy Industry signed a long-term production agreement for offshore wind power foundations, with a total value of about 1.25 billion yuan [24] Group 7 - Zhendong Medical's controlling shareholder plans to transfer 5% of the company's shares [25] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [26] - BYD's senior management and core personnel collectively increased their holdings by approximately 52.33 million yuan [27] Group 8 - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.94% [28] - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% [30] - Lanke Technology's shareholders plan to reduce their holdings by up to 2% [31]

Core Viewpoint - Aoyang Health (stock code: 002172) announced that its stock will continue to be suspended from trading starting September 11, 2025, with an expected suspension period of no more than three trading days [1] Company Summary - Aoyang Health's stock will remain suspended from trading for a maximum of three trading days [1]

Regulatory Actions - Baiyin Nonferrous Metals has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws [3] - ST Haofeng announced that Zhixin Network will become the controlling shareholder after a share transfer agreement, with shares resuming trading on September 11, 2025 [7] - Fushun Special Steel will suspend trading for one day due to a share buyback offer, with a total of 9.865 million shares being offered at a price of 5.6 yuan per share [8] Operational Updates - Qingshan Paper Industry reported that its production and operational activities are normal, with no significant changes in daily operations [4] - Aoyang Health announced that its stock will continue to be suspended due to ongoing negotiations regarding a share transfer, with an expected suspension period of no more than three trading days [5] - ST Jinke will implement a capital reserve transfer to increase share capital, leading to a one-day trading suspension [6] Major Contracts and Projects - Shaanxi Construction Group won four construction projects each exceeding 500 million yuan in August, including a 2.4 billion yuan project for a solar hydrogen production facility [11] - Demar Technology secured a 2.9 billion yuan contract for an intelligent logistics project with a well-known e-commerce giant in Latin America [13] - Mongolian Grass Ecology's subsidiary led a consortium that won a 2.25 billion yuan project for ecological protection and restoration in Inner Mongolia [14] - Sanfeng Environment signed a contract worth approximately 2.6 billion Macanese Patacas for waste management services in Macau, with a contract duration of 10 years [15] Shareholding Changes - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.94% through market transactions [17] - Sichuan Road and Bridge's controlling shareholder intends to reduce its stake by up to 2% through block trades [18] - Hexing Co., Ltd. announced that its controlling shareholder plans to reduce its stake by up to 3% through various trading methods [19] - Jingfang Technology's shareholder terminated its share reduction plan without executing any sales during the period [20]

Group 1 - The core point of the article is that Aoyang Health (002172.SZ) is in active negotiations regarding an overall transaction plan, but has not yet signed a formal agreement [1] - The company anticipates that it will not be able to resume trading on September 11, 2025, at the market opening [1] - Aoyang Health has applied to the Shenzhen Stock Exchange for an extension of its stock suspension, which is expected to last no more than three trading days [1]

Group 1 - The core point of the article is that Aoyang Health (002172.SZ) is in active negotiations regarding an overall transaction plan, but has not yet signed a formal agreement [1] - The company anticipates that it will not be able to resume trading on September 11, 2025, at the market opening [1] - Aoyang Health has applied to the Shenzhen Stock Exchange for an extension of its stock suspension, which is expected to last no more than three trading days [1]

Group 1 - The core point of the article is that Aoyang Health (002172.SZ) announced that its controlling shareholder, Aoyang Group, is planning to transfer shares, which may lead to a change in the controlling shareholder and actual controller of the company [1] - The company’s stock was suspended from trading on September 9, 2025, due to this announcement [1] - As of the announcement date, the parties involved are actively negotiating the overall transaction plan, but no formal agreement has been signed yet [1] Group 2 - The company anticipates that it will not be able to resume trading on September 11, 2025, and the stock will continue to be suspended [1] - The expected suspension period is not more than three trading days [1]

Core Viewpoint - Aoyang Health (002172) announced on September 10 that its controlling shareholder, Aoyang Group, is planning to transfer company shares, with ongoing negotiations for the overall transaction scheme [1] Group 1 - As of the announcement date, the parties involved have not yet signed a formal agreement and are actively preparing for the transaction [1] - The company expects that it will not be able to resume trading on September 11, 2025, at the market opening [1] - The company's stock will continue to be suspended from trading starting September 11, 2025, with an expected suspension period of no more than three trading days [1]

Core Viewpoint - The company, Aoyang Health (002172.SZ), announced that its controlling shareholder, Aoyang Group, is planning to transfer shares, which may lead to a change in the controlling shareholder and actual controller of the company [1] Group 1 - Aoyang Group notified the company on September 8, 2025, regarding the share transfer plan, with specific ratios and transaction methods to be determined through further negotiations [1] - The company's stock was suspended from trading on September 9, 2025, due to this announcement [1] - As of the announcement date, the parties involved are actively negotiating the overall transaction plan, and no formal agreement has been signed yet [1] Group 2 - The company anticipates that it will not be able to resume trading on September 11, 2025, and the stock will continue to be suspended [1] - The expected duration of the trading suspension is no more than three trading days [1]

关于筹划公司控制权变更事项进展暨继续停牌的公告 证券代码：002172 证券简称：澳洋健康 公告编号：2025-28 江苏澳洋健康产业股份有限公司 关于筹划公司控制权变更事项进展暨继续停牌的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 特别提示： 1、江苏澳洋健康产业股份有限公司（以下简称"公司"）股票（股票简称 澳洋健康，股票代码：002172）于 2025 年 9 月 11 日（星期四）上午开市起继续 停牌，预计停牌时间不超过 3 个交易日。 一、停牌事项概述 公司于 2025 年 9 月 8 日接到控股股东澳洋集团有限公司（以下简称"澳洋 集团"）的通知，澳洋集团正在筹划公司股份转让事宜（具体比例及交易方式待 交易双方进一步商议确定），该事项可能导致公司控股股东及实际控制人发生变 更。 鉴于上述事项处于洽谈阶段，尚存在重大不确定性，为保证信息披露公平， 维护广大投资者利益，根据《深圳证券交易所股票上市规则》《深圳证券交易所 上市公司自律监管指引第 6 号——停复牌》的相关规定，经公司申请，公司股票 （股票简称：澳洋健康，股票代码：00 ...